covid 19 News and Research

RSS

Pregnancy and fetal outcomes with COVID-19

A new study published preprint in the non-peer-reviewed journal medRxiv in April 2020 provides a systematic review of maternal and fetal outcomes in pregnancy affected by COVID-19, as well as the risk of vertical transmission of the virus.

16 Apr 2020

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

A drug called auranofin, approved for the treatment of rheumatoid arthritis, effectively inhibits severe acute respiratory syndrome coronavirus (SARS-CoV-2) in laboratory conditions, as described in a new study by Georgia State University researchers.

16 Apr 2020

Mental health may be significantly impacted by COVID-19-related social distancing and isolation

A study conducted by a team of psychologists and social scientists has revealed that the social distancing and isolation measures introduced in the UK as a result of COVID-19 may already be having significant negative impacts on people's mental health and well-being.

16 Apr 2020

Interactive tool helps identify potential shortages of COVID-19 workforce

As the U.S. healthcare workforce struggles to care for a rise in COVID-19 cases, there are growing reports that there are not enough workers to meet the surge in demand.

16 Apr 2020

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

With the COVID-19 pandemic continuing to spread across the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

16 Apr 2020

The benefits of breastfeeding during COVID-19 crisis

While the current coronavirus pandemic continues to affect all people, families will still give birth and bring new life into the world.

16 Apr 2020

Researchers design peptide inhibitors for potential COVID-19 treatments

Scientists across the globe are rushing to find inhibitors of SARS-CoV-2, the new coronavirus behind the COVID-19 pandemic.

16 Apr 2020

Specialized proteins could soak up excess cytokines in COVID-19 patients

One of the defining features of Covid-19 is the excessive immune response that can occur in severe cases. This burst of immune overreaction, also called a cytokine storm, damages the lungs and can be fatal.

16 Apr 2020

Big brother wants to track your location and health data. And that’s not all bad.

A growing mix of health and technology experts are convinced that if the United States is to ever effectively track the coronavirus and slow its spread, then both self-reported and more surreptitiously gathered personal data — a mix of information about location, travel, symptoms and health conditions - must be gathered from millions of Americans.

16 Apr 2020

Trial to evaluate how blood pressure medications affect outcomes among COVID-19 patients

A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.

16 Apr 2020

Caring for geriatric patients during COVID-19 pandemic requires vigilance

As the coronavirus disease (COVID-19) pandemic advances so does the uncertainty and evolution of the pandemic as it relates to nursing homes and long-term care facilities

16 Apr 2020

KHN’s ‘What the Health?’: How will we reopen the economy?

President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.

16 Apr 2020

‘I wasn’t eating’: Senior twin sisters battle pandemic anxiety together

Ethel Sylvester dialed 911, trembling with fear. The 92-year-old felt hot. She thought turning off her thermostat could fix the problem. That didn't help.

16 Apr 2020

Octapharma USA supports new COVID-19 clinical trial

Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, M.D. of Sharp Memorial Hospital in San Diego, California focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing respiratory failure who become ventilator dependent.

16 Apr 2020

Public health precautions to lower airborne transmission of COVID-19 virus

Researchers are urging health authorities to immediately recognize the role of airborne transmission of COVID-19 virus droplets from an infected person beyond 1.5m in order to stem the disease’s spread.

16 Apr 2020

N.Y. leads the nation in COVID-19 tests, but the effort still lags behind demand

This jampacked city, with its high-rises, brownstones and cheek-by-jowl single-family homes, is a ripe environment for the novel coronavirus that has killed more than 11,000 residents. That density also complicates a key strategy for alleviating the epidemic: testing.

16 Apr 2020

Jails and prisons spring thousands to prevent coronavirus outbreaks

Terry Smith, a 65-year-old Vietnam veteran with PTSD, multiple health issues and a history of homelessness, spent nearly three years in San Francisco County Jail awaiting trial on a burglary charge. The final several weeks were served in the full flush of a burgeoning viral pandemic.

16 Apr 2020

Coronavirus nurses ask an Ebola veteran: Is it OK to be afraid?

Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.

16 Apr 2020

Canadian Coalition Fosters Collaboration in Fight Against COVID-19

A group of Canadian biotech companies are joining forces in the war on COVID-19 with an open-source model using next-generation antidotes known as nanobodies1.

From SignalChem Biotech Inc. 16 Apr 2020

Horizon Discovery offers rapid access to CHOSOURCE platform for development of COVID-19 therapies

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.

16 Apr 2020